{"product_id":"retatrutide-60mg","title":"RETATRUTIDE (60mg)","description":"\u003cp class=\"MsoNormal\" style=\"margin-bottom: 9.0pt;\"\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eThis 60mg presentation of retatrutide supports extended research protocols or investigations requiring higher cumulative compound availability. Retatrutide's triple agonism of GLP-1, GIP, and glucagon receptors continues to set new benchmarks in obesity pharmacology research, with Phase 2 data reporting weight reductions of up to 24% of body weight.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 6.0pt 0in 5.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003eMechanism of Action\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eSimultaneous GLP-1, GIP, and glucagon receptor activation drives complementary metabolic benefits in research models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eGLP-1\/GIP agonism studied for appetite modulation and glycemic control; glucagon agonism investigated for caloric expenditure and hepatic fatty acid oxidation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eResearch shows comprehensive visceral and hepatic fat reduction through multi-pathway metabolic modulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 7.0pt 0in 5.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003eResearch Areas\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eAdvanced obesity pharmacology research requiring extended study supply.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eMulti-cycle weight loss and plateau management studies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eNAFLD\/NASH biology combined with metabolic syndrome research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 7.0pt 0in 4.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003ePresentation and Storage\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 3.0pt;\"\u003e\u003ci\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #444444;\"\u003eSupplied as a lyophilized powder in a sealed vial containing 60mg of retatrutide. Reconstitute with bacteriostatic water for laboratory use. Store at -20C.\u003c\/span\u003e\u003c\/i\u003e\u003c\/p\u003e","brand":"bioreverselabs.com","offers":[{"title":"Default Title","offer_id":45913610256557,"sku":null,"price":5950.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0761\/1577\/1565\/files\/100MG_4.png?v=1776320118","url":"https:\/\/bioreverselabs.com\/products\/retatrutide-60mg","provider":"Bio Reverse Labs","version":"1.0","type":"link"}